These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Modification of xenograft hyperacute rejection via xenoantibody depletion. Henry ML; Han LK; Orosz CG; Sedmak D; Ferguson RM Transplant Proc; 1990 Jun; 22(3):1081-2. PubMed ID: 2349665 [No Abstract] [Full Text] [Related]
5. The role of macrophages in xenograft rejection. Cadili A; Kneteman N Transplant Proc; 2008 Dec; 40(10):3289-93. PubMed ID: 19100374 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and endothelins are effector agents of hyperacute vascular rejection. Castillo J; Berrazueta JR; Herrera L; de Vega MJ; Val JF; Amado JA; Gómez J; Gómez-Fleitas M Transplant Proc; 1996 Apr; 28(2):635. PubMed ID: 8623316 [No Abstract] [Full Text] [Related]
7. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide. Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273 [TBL] [Abstract][Full Text] [Related]
8. The immunological barriers to xenotransplantation. Platt JL Crit Rev Immunol; 1996; 16(4):331-58. PubMed ID: 8954254 [TBL] [Abstract][Full Text] [Related]
9. Factors determining the onset of hyperacute rejection following discordant porcine-to-cynomolgus monkey kidney xenotransplantation. Loss M; Przemeck M; Schmidtko J; Kunz R; Jalali A; Arends H; Lorenz R; Rensing S; Kaup FJ; Jäger K; White DJ; Klempnauer J; Winkler M Transplant Proc; 2000 Aug; 32(5):1098. PubMed ID: 10936375 [No Abstract] [Full Text] [Related]
10. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives]. Malassagne B; Calmus Y; Houssin D; Weill B Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402 [TBL] [Abstract][Full Text] [Related]
11. The effect of xenoantibody and formed cellular blood elements on ex vivo xenograft hyperacute rejection. Han LK; Henry ML; Ferguson RM Transplant Proc; 1991 Feb; 23(1 Pt 1):574-5. PubMed ID: 1990612 [No Abstract] [Full Text] [Related]
12. Rejection mechanisms in transplantation. Game DS; Warrens AN; Lechler RI Wien Klin Wochenschr; 2001 Oct; 113(20-21):832-8. PubMed ID: 11732119 [TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro study of hyperacute rejection mechanism of renal discordant xenograft. Marino IR; Ferla G; Celli S; Stieber A; Muttillo I; Maggiano N; Perrelli L; Musiani P Transplant Proc; 1991 Feb; 23(1 Pt 1):620-2. PubMed ID: 1990627 [No Abstract] [Full Text] [Related]
14. [The advances in immunological research on xenotransplantation]. Feng L; Li YP Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jul; 16(4):284-7. PubMed ID: 12181800 [TBL] [Abstract][Full Text] [Related]
15. The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS. Saumweber DM; Bergmann R; Gokel M; Brecht HM; Hammer C Transplant Proc; 1991 Feb; 23(1 Pt 1):576-8. PubMed ID: 1990613 [No Abstract] [Full Text] [Related]
16. Xenotransplantation: is this the future? Hancock WW Semin Nephrol; 2000 Mar; 20(2):217-29. PubMed ID: 10746863 [TBL] [Abstract][Full Text] [Related]